O
PMC

OppenheimerFunds’s PharMerica Corporation PMC Stock Holding History

OppenheimerFunds’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-92,729
Closed -$2.72M – 1905
2017
Q3 		$2.72M Buy
92,729
+30,416
+49% +$852K ﹤0.01% 874
2017
Q2 		$1.64M Sell
62,313
-7,252
-10% -$178K ﹤0.01% 997
2017
Q1 		$1.63M Buy
69,565
+17,364
+33% +$429K ﹤0.01% 1008
2016
Q4 		$1.31M Buy
52,201
+15,150
+41% +$382K ﹤0.01% 1021
2016
Q3 		$1.04M Buy
37,051
+675
+2% +$17.3K ﹤0.01% 1012
2016
Q2 		$897K Sell
36,376
-3,954
-10% -$98.1K ﹤0.01% 1029
2016
Q1 		$892K Buy
40,330
+6,332
+19% +$169K ﹤0.01% 1037
2015
Q4 		$1.19M Buy
+33,998
New +$1.06M ﹤0.01% 1001

OppenheimerFunds's PMC Position: Q4 2017 in Review

OppenheimerFunds sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 92,729 shares — an estimated $2.72M sold.

OppenheimerFunds first reported a position in PMC in Q4 2015 and held it in 8 quarters. The position peaked at $2.72M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • OppenheimerFunds reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • OppenheimerFunds sold 92,729 PharMerica Corporation shares in Q4 2017, an estimated $2.72M.
  • OppenheimerFunds first reported a position in PharMerica Corporation in Q4 2015 and held it in 8 quarters.
  • OppenheimerFunds's PharMerica Corporation position peaked at $2.72M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.